Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

AGM Statement

4 Nov 2021 07:00

RNS Number : 2799R
Induction Healthcare Group PLC
04 November 2021
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

AGM Statement

£11.2m contracted revenues already secured for the current financial year

 

Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, provides an update to shareholders ahead of its Annual General Meeting ('AGM') being held today at 50 Liverpool Street, London EC2M 7PY at 9.00 am.

 

At the meeting James Balmain, Chief Executive Officer, will make the following statement:

 

"I am very pleased to welcome shareholders to our Annual General Meeting and to provide them with a short update on the strong performance we have experienced in the first half of the new financial year, underpinning our expectations for the full year.

 

"As highlighted in our recent Final Results statement we continue to see growing demand for our flexible care platforms. As health systems around the world continue to execute their pandemic recovery plans, we're seeing rapidly increasing levels of investment from both local providers and regional care systems. The acquisition of Attend Anywhere in June further enhances our leading market position and gives us comprehensive coverage of the secondary care patient pathway by allowing us to offer appointment booking, remote data capture and the full range of telephone and video consultations.

 

"The Group currently has £11.2m of contracted revenues secured for the financial year ending 31 March 2022, and the integration and realisation of cost synergies with Attend Anywhere are proceeding better than expected and this is providing the Board with confidence that we are in line to meet market expectations for the full year.

 

"We go into the remainder of the financial year with a strong pipeline of potential new contracts and renewals, and we continue to see a substantial increase in patient and clinical users. We are very excited about the prospects for the Company and look forward to updating shareholders as our strong sales momentum continues."

 

 

ENQUIRIES

 

Induction

James Balmain, Chief Executive Officer

Dr Hugo Stephenson, Group Executive Director

Via Walbrook PR Ltd: induction@walbrookpr.com

Singer Capital Markets (Nominated Adviser and Broker)

+44 (0) 20 7496 3000

Philip Davies / Kailey Aliyar

Walbrook PR Ltd 

induction@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

About Induction - www.inductionhealthcare.com

 

Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.

 

More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

 

Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone.

 

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFSFFUDEFSESF
Date   Source Headline
27th Jul 202210:30 amRNSBlock Listing Six Monthly Return
11th Jul 20227:00 amRNSDistribution agreement for Zesty with System C
5th Jul 20227:01 amEQSEdison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare
7th Jun 20227:00 amRNSDirectorate Change
31st May 202212:58 pmRNSHolding(s) in Company
4th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
21st Apr 20227:00 amRNSPost-period end Trading Update
13th Apr 20224:01 pmRNSHolding(s) in Company
12th Apr 20224:00 pmRNSPurchase of Shares by Director
12th Apr 202212:11 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSPurchase of Shares by Directors
11th Apr 20227:00 amRNSNHS England contract renewals secure £6.6m ARR
7th Apr 20229:27 amRNSHolding(s) in Company
4th Apr 20227:00 amRNSFour London NHS Trusts sign with Induction Zesty
30th Mar 202211:00 amRNSAIM Rule 17 Schedule 2(g) Update
21st Mar 20227:00 amRNSNHS Scotland & Scottish Govt. Contract Renewals
26th Jan 20227:00 amRNSBlock Listing Six Monthly Return
6th Dec 20217:00 amRNSInduction AA rolls out new services nationwide
2nd Dec 202112:20 pmRNSPurchase of Shares by Directors
2nd Dec 20217:00 amRNSUnaudited Interim Results
26th Nov 20217:00 amRNSNotice of Half-year Results
15th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSInduction Attend Anywhere wins DWP contract
4th Nov 202110:52 amRNSResult of AGM
4th Nov 20217:00 amRNSAGM Statement
25th Oct 20217:00 amRNSReport on Video Consultations in Secondary Care
28th Sep 20217:00 amRNSPublication of Annual Report & Notice of AGM
23rd Sep 20217:00 amRNSFinal results for the year ended 31 March 2021
7th Sep 20217:00 amRNSDirectorate Changes
2nd Sep 20219:16 amRNSHolding(s) in Company
31st Aug 202111:04 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSBlock Listing Application
20th Jul 20217:00 amRNSMajor contract renewed with increased scope
16th Jun 20213:45 pmRNSHolding(s) in Company
11th Jun 20218:00 amRNSHolding(s) in Company
10th Jun 20214:18 pmRNSHolding(s) in Company
9th Jun 20218:00 amRNSCompletion of Acquisition of Attend Anywhere
8th Jun 20215:18 pmRNSHolding(s) in Company
7th Jun 202110:20 amRNSResult of General Meeting
21st May 20217:00 amRNSProposed Acquisition of Attend Anywhere Pty Ltd
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:06 amRNSSecond Price Monitoring Extn
18th May 202111:01 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSMultiple new hospital contracts for InductionZesty
25th Mar 20217:00 amRNSMulti-year hospital contract for Induction Switch
22nd Mar 20217:00 amRNSZesty surpasses 200k registered patients in the UK

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.